Diagnostic significance of serum HMGB1 in colorectal carcinomas
about
Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in CancerClinical Value of High Mobility Group Box 1 and the Receptor for Advanced Glycation End-products in Head and Neck Cancer: A Systematic ReviewHMGB1 in health and disease.Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells.Prognostic Significance of Tag SNP rs1045411 in HMGB1 of the Aggressive Gastric Cancer in a Chinese Population.Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progressionRelationship between high-mobility group box 1 overexpression in ovarian cancer tissue and serum: a meta-analysis.Immunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation.The association of HMGB1 expression with clinicopathological significance and prognosis in Asian patients with colorectal carcinoma: a meta-analysis and literature reviewImmune-mediated liver injury of the cancer therapeutic antibody catumaxomab targeting EpCAM, CD3 and Fcγ receptors.HMGB1 level in cerebrospinal fluid as a complimentary biomarker for the diagnosis of tuberculous meningitisTying the knot between cytokine and toll-like receptor signaling in gastrointestinal tract cancers.The multifunctional alarmin HMGB1 with roles in the pathophysiology of sepsis and cancer.Association of high mobility group BOX-1 and receptor for advanced glycation endproducts with clinicopathological features of haematological malignancies: a systematic review.Mass spectrometry-based proteomics in molecular diagnostics: discovery of cancer biomarkers using tissue culture.HMGB1: A Promising Therapeutic Target for Prostate Cancer.Secreted HMGB1 from Wnt activated intestinal cells is required to maintain a crypt progenitor phenotype.The dual role and therapeutic potential of high-mobility group box 1 in cancer.High mobility group box 1 promotes sorafenib resistance in HepG2 cells and in vivo.Cell Line Secretome and Tumor Tissue Proteome Markers for Early Detection of Colorectal Cancer: A Systematic Review.Cytosolic high-mobility group box protein 1 (HMGB1) and/or PD-1+ TILs in the tumor microenvironment may be contributing prognostic biomarkers for patients with locally advanced rectal cancer who have undergone neoadjuvant chemoradiotherapy.High Expression of High-Mobility Group Box 1 in Menstrual Blood: Implications for Endometriosis.Liver protein profiles in insulin receptor-knockout mice reveal novel molecules involved in the diabetes pathophysiology.Hypothesis and data-driven dietary patterns and colorectal Cancer survival: findings from Newfoundland and Labrador colorectal Cancer cohort.HMGB1 promotes ERK-mediated mitochondrial Drp1 phosphorylation for chemoresistance through RAGE in colorectal cancerOverexpression of High-Mobility Motor Box 1 in the Blood and Tissues of Patients with Head and Neck Squamous Cell Carcinoma
P2860
Q26795466-DDD51409-1AE7-46AE-A046-212E0EE5033FQ28074543-ACF49C1E-12B4-409B-9F35-DE6A3FDB71AFQ34622835-9F7CEAF5-DF26-4861-AC14-E301E9F25152Q34750515-CE0A2341-04C5-4C8F-99E5-2EAB4EA4124AQ35523700-0BD05ACE-A23F-4638-BC9E-54A743ED0C3AQ35999764-3BBE026C-7FFC-4348-9EF2-B2DF7A8BCD54Q36347346-9C9D7357-224B-43CC-B03F-7C4BAFF95A29Q36347619-A709E952-1237-423B-951B-7C48EF6A0D29Q36985164-FCC11ACE-21AA-4ED0-B2E4-D98252DDB373Q37170567-0BDA430D-A5DC-42AA-AC26-E4F25F2A3651Q37317487-1D8F6269-9354-4D9D-A58E-76230FB53DDDQ37334747-E7614039-DF51-4244-9E7F-B2E0179B88FBQ38109656-58923D9F-929D-4974-A65C-4BC88C914C04Q38116712-038828A6-4665-49FF-973E-40B63E810F8EQ39151877-C9FD7CCE-8EE2-4109-81E2-6C72679C60A0Q39468169-EFD6A8A4-356E-4CC6-8C3D-916BF33C1A7BQ41136849-0B85B993-A203-44E0-9B19-5A76A63190B6Q41870623-2CBC0963-6C2E-4D7A-98B7-02BEB3BD1653Q42362799-3FC48232-4687-488B-88BC-7AA5B48FE9DAQ47135468-F05D7122-B7C2-46E7-9181-E66A2316445EQ47168994-E0DCE819-B62E-4B1F-A18F-E849AF825674Q47262101-09974EBE-B12B-4D49-8CBD-5B445BA3703CQ50090494-8A63B10F-2A86-4D77-9F70-C312314B5AB8Q54288262-66594838-BE70-4C02-AE9B-EFA2283A7E86Q55226097-632470CF-623C-457B-80D8-1A6A0B9D2609Q58695345-353EA609-AE43-49D1-A746-E26B568DBFBBQ58774321-EF727399-7811-4573-8746-CA24E17005DA
P2860
Diagnostic significance of serum HMGB1 in colorectal carcinomas
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Diagnostic significance of serum HMGB1 in colorectal carcinomas
@ast
Diagnostic significance of serum HMGB1 in colorectal carcinomas
@en
Diagnostic significance of serum HMGB1 in colorectal carcinomas
@nl
type
label
Diagnostic significance of serum HMGB1 in colorectal carcinomas
@ast
Diagnostic significance of serum HMGB1 in colorectal carcinomas
@en
Diagnostic significance of serum HMGB1 in colorectal carcinomas
@nl
prefLabel
Diagnostic significance of serum HMGB1 in colorectal carcinomas
@ast
Diagnostic significance of serum HMGB1 in colorectal carcinomas
@en
Diagnostic significance of serum HMGB1 in colorectal carcinomas
@nl
P2093
P2860
P1433
P1476
Diagnostic significance of serum HMGB1 in colorectal carcinomas
@en
P2093
Byung Soh Min
Chang Hoon Shin
Hoguen Kim
Jong Shin Yoo
Meiying Song
P2860
P304
P356
10.1371/JOURNAL.PONE.0034318
P407
P50
P577
2012-04-04T00:00:00Z